RGLS Annual CAPEX
N/A
31 December 2023
Summary:
RGLS annual capital expenditures is not available.RGLS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGLS Quarterly CAPEX
N/A
30 September 2024
Summary:
RGLS quarterly capital expenditures is not available.RGLS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGLS TTM CAPEX
N/A
30 September 2024
Summary:
RGLS TTM capital expenditures is not available.RGLS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGLS CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
RGLS CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Regulus Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $11.00 K(-95.5%) | $0.00(-100.0%) | $11.00 K(-84.3%) |
| Sept 2020 | - | $11.00 K(-81.4%) | $70.00 K(-71.3%) |
| Dec 2019 | $244.00 K(+1009.1%) | $59.00 K(-66.7%) | $244.00 K(+31.9%) |
| Sept 2019 | - | $177.00 K(+2112.5%) | $185.00 K(+516.7%) |
| June 2019 | - | $8000.00(>+9900.0%) | $30.00 K(+36.4%) |
| Dec 2018 | $22.00 K(-93.1%) | $0.00(-100.0%) | $22.00 K(-79.6%) |
| Sept 2018 | - | $22.00 K(-74.4%) | $108.00 K(-66.1%) |
| Dec 2017 | $319.00 K(-67.0%) | $86.00 K(-7.5%) | $319.00 K(-21.2%) |
| Sept 2017 | - | $93.00 K(-720.0%) | $405.00 K(-49.8%) |
| June 2017 | - | -$15.00 K(-109.7%) | $806.00 K(+12.7%) |
| Mar 2017 | - | $155.00 K(-9.9%) | $715.00 K(-26.0%) |
| Dec 2016 | $966.00 K(-32.4%) | $172.00 K(-65.2%) | $966.00 K(-26.3%) |
| Sept 2016 | - | $494.00 K(-566.0%) | $1.31 M(+0.8%) |
| June 2016 | - | -$106.00 K(-126.1%) | $1.30 M(-18.3%) |
| Mar 2016 | - | $406.00 K(-21.5%) | $1.59 M(+11.4%) |
| Dec 2015 | $1.43 M | $517.00 K(+6.8%) | $1.43 M(+50.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $484.00 K(+160.2%) | $951.00 K(+8.7%) |
| June 2015 | - | $186.00 K(-23.5%) | $875.00 K(-36.5%) |
| Mar 2015 | - | $243.00 K(+539.5%) | $1.38 M(+13.9%) |
| Dec 2014 | $1.21 M(+45.0%) | $38.00 K(-90.7%) | $1.21 M(-10.6%) |
| Sept 2014 | - | $408.00 K(-40.9%) | $1.35 M(+9.5%) |
| June 2014 | - | $690.00 K(+820.0%) | $1.24 M(+53.3%) |
| Mar 2014 | - | $75.00 K(-58.6%) | $806.00 K(-3.5%) |
| Dec 2013 | $835.00 K(-41.4%) | $181.00 K(-37.6%) | $835.00 K(-28.7%) |
| Sept 2013 | - | $290.00 K(+11.5%) | $1.17 M(+26.5%) |
| June 2013 | - | $260.00 K(+150.0%) | $926.00 K(-19.8%) |
| Mar 2013 | - | $104.00 K(-79.9%) | $1.15 M(-19.1%) |
| Dec 2012 | $1.43 M(+138.5%) | $517.00 K(+1048.9%) | $1.43 M(+56.9%) |
| Sept 2012 | - | $45.00 K(-90.8%) | $909.00 K(+5.2%) |
| June 2012 | - | $488.00 K(+29.8%) | $864.00 K(+129.8%) |
| Mar 2012 | - | $376.00 K | $376.00 K |
| Dec 2011 | $598.00 K(-75.2%) | - | - |
| Dec 2010 | $2.42 M | - | - |
FAQ
- What is the all time high annual CAPEX for Regulus Therapeutics?
- What is the all time high quarterly CAPEX for Regulus Therapeutics?
- What is the all time high TTM CAPEX for Regulus Therapeutics?
What is the all time high annual CAPEX for Regulus Therapeutics?
Regulus Therapeutics all-time high annual capital expenditures is $2.42 M
What is the all time high quarterly CAPEX for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly capital expenditures is $690.00 K
What is the all time high TTM CAPEX for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM capital expenditures is $1.59 M